Lola Anagnostaki

Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics

Anita Ringberg, Lola Anagnostaki, H. Anderson et al. · European Journal of Cancer · 2001 · 105 citations

Medicine, Oncology, Pathology +17

HMG‐CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors

Signe Borgquist, Soraya Djerbi, Fredrik Pontén et al. · International Journal of Cancer · 2008 · 64 citations

Medicine, Endocrinology, Oncology +13

Oestrogen receptors α and β show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer

Signe Borgquist, Caroline Holm, Maria Stendahl et al. · Journal of Clinical Pathology · 2008 · 64 citations

Medicine, Endocrinology, Oncology +14

Breast tumours following combined hormone replacement therapy express favourable prognostic factors

Signe Borgquist, Lola Anagnostaki, Karin Jirström et al. · International Journal of Cancer · 2007 · 58 citations · Full text

Medicine, Endocrinology, Oncology +15

Expression and localization of serotonin receptors in human breast cancer.

Pradeep Kumar Kopparapu, Martina Tinzl, Lola Anagnostaki et al. · PubMed · 2013 · 55 citations

Medicine, Cancer Biology, Oncology +14